Across TCGA pan-cancer cohorts, POM121L4P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated POM121L4P data layer compared with 18 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher POM121L4P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated POM121L4P expression acts as an unfavorable survival marker.

UCEC, ESCA, and COAD are the cancer types where POM121L4P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
ESCA	DFS	Median	All	0.098	0.533	.003	6	view →
COAD	DFS	Median	All	0.464	0.785	.030	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: POM121L4P tumor-vs-normal RNA expression · all POM121L4P data types